Literature DB >> 2542007

Antagonism of contractants and relaxants at the level of intracellular calcium and phosphoinositide turnover in the rat uterus.

K Anwer1, J A Hovington, B M Sanborn.   

Abstract

The effects of the uterine relaxants relaxin and isoproterenol on intracellular free calcium and inositol phosphate formation were investigated in rat myometrium. Preincubation of fura-2-loaded myometrial cell suspensions with relaxin and isoproterenol inhibited the oxytocin-induced stimulation of intracellular free calcium, with EC50 values of 0.02 and 1.0 microM, respectively. Pretreatment of cells with pertussis toxin or replacement of extracellular calcium with 2 mM EGTA inhibited the oxytocin-induced increase in intracellular calcium by 47% and 50%, respectively, but did not inhibit the action of relaxin. (Bu)2cAMP and forskolin also inhibited the effect of oxytocin on intracellular calcium. In uterine strips prelabeled with [3H]inositol, oxytocin stimulated a dose-dependent accumulation of inositol monophosphate, inositol bisphosphate, and inositol trisphosphate, with and EC50 of 0.38 microM, and pertussis toxin inhibited this effect. Relaxin, isoproterenol, chlorophenylthio-cAMP, and forskolin inhibited the oxytocin-stimulated formation of inositol monophosphate, inositol bisphosphate, and inositol trisphosphate. The effect of relaxin on inositol trisphosphate formation was dose dependent, with an EC50 of 0.1 microM. Relaxin and isoproterenol also inhibited inositol phosphate formation in myometrial cells. These data demonstrate the attenuation of contractant-induced elevation in myometrial intracellular calcium and phosphoinositide turnover by uterine relaxants and suggest that these actions may be related. In addition, they provide additional evidence that cAMP-mediated mechanisms may be involved in mediating uterine relaxation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542007     DOI: 10.1210/endo-124-6-2995

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 2.  Uterotonic plants and their bioactive constituents.

Authors:  Christian W Gruber; Margaret O'Brien
Journal:  Planta Med       Date:  2010-09-15       Impact factor: 3.352

3.  Alpha-1, alpha-2, and beta adrenergic signal transduction in cultured uterine myocytes.

Authors:  M Phillippe; T Saunders; S Bangalore
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

4.  Prostaglandins and muscarinic agonists induce cyclic AMP attenuation by two distinct mechanisms in the pregnant-rat myometrium. Interaction between cyclic AMP and Ca2+ signals.

Authors:  O Goureau; Z Tanfin; S Harbon
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium.

Authors:  K J Baek; N S Kwon; H S Lee; M S Kim; P Muralidhar; M J Im
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

6.  The inhibitory action of cyclic AMP on responses to carbachol dependent on calcium stores in rat gastric smooth muscle.

Authors:  T Ohta; S Ito; T Noto; R Tachibana; Y Nakazato; A Ohga
Journal:  J Physiol       Date:  1992       Impact factor: 5.182

7.  G-protein involvement in muscarinic receptor-stimulation of inositol phosphates in longitudinal smooth muscle from the small intestine of the guinea-pig.

Authors:  S A Prestwich; T B Bolton
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Oxytocin mobilizes calcium from a unique heparin-sensitive and thapsigargin-sensitive store in single myometrial cells from pregnant rats.

Authors:  S Arnaudeau; N Leprêtre; J Mironneau
Journal:  Pflugers Arch       Date:  1994-08       Impact factor: 3.657

9.  Dexmedetomidine modifies uterine contractions in pregnancy terms of rats.

Authors:  Işil Öcal; Yasemin Güneş; Tufan Mert; Dilek Özcengiz; Ismail Günay
Journal:  Indian J Pharmacol       Date:  2013 Mar-Apr       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.